Therefore, the reduction in STAT3 by SA14 overexpression may also alleviate MSH in tumour cells and reduce the accumulation of neoantigens, which might blunt the antitumour effect of anti‐PD‐L1 immunotherapy. The gene discussed is CD274; the disease is neoplasm.